Stocks and Investing
Stocks and Investing
Tue, January 12, 2021
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
Joel Beatty Downgraded (SRPT) to Hold and Held Target at $108 on, Jan 12th, 2021
Joel Beatty of Citigroup, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Held Target at $108 on, Jan 12th, 2021.
Joel has made no other calls on SRPT in the last 4 months.
There are 8 other peers that have a rating on SRPT. Out of the 8 peers that are also analyzing SRPT, 4 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Colin Bristow of "UBS" Downgraded from Strong Buy to Hold on, Monday, January 11th, 2021
- Danielle Brill of "Raymond James" Downgraded from Buy to Hold on, Friday, January 8th, 2021
- Martin Auster of "Credit Suisse" Maintained at Hold with Decreased Target to $73 on, Friday, January 8th, 2021
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $95 on, Friday, January 8th, 2021
These are the ratings of the 4 analyists that currently disagree with Joel
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $125 on, Friday, January 8th, 2021
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $135 on, Friday, January 8th, 2021
- Anupam Rama of "JP Morgan" Downgraded from Buy to Sell and Held Target at $96 on, Friday, January 8th, 2021
- Chad Messer of "Needham" Maintained at Strong Buy with Decreased Target to $166 on, Friday, January 8th, 2021
Contributing Sources